LINEAGE CELL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9753 USD | +0.28% |
|
+4.87% | -10.52% |
| 05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
| 05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.28% | +4.87% | -10.52% | -23.80% | -3.44% | 184M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Comparison Chart